T1	Participants 141 192	patients with advanced chronic heart failure (CHF).
T2	Participants 324 341	patients with CHF
T3	Participants 374 537	23 patients in NYHA class II and III (20 men, three women, mean age 59+/-9 years) with stable CHF secondary to ischaemic heart disease [ejection fraction 37+/-7%],